跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
TOBRA-DAY tobramycin (as sulfate) 500mg/5 mL Injection vial
Approved
STANDARD
TOBRA-DAY tobramycin (as sulfate) 500mg/5 mL Injection vial
Phebra Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
2a59fd59c2455df3
Company
Phebra Pty Ltd
Type
Standard
Approval Details
Approval Id
2a59fd59c2455df3
Product Name
TOBRA-DAY tobramycin (as sulfate) 500mg/5 mL Injection vial
Artg Id
150481
Artg Name
TOBRA-DAY tobramycin (as sulfate) 500mg/5 mL Injection vial
Sponsor
Phebra Pty Ltd
Company Detail Path
/organization/phebra-pty-ltd
Artg Date
2009-07-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a2e31e55e38c6aabd6948ec2367ed312.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b5ccb2256dad873d921832d45e1018b4.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
2a59fd59c2455df3
Type
Standard
Back to TGA Approvals
TOBRA-DAY tobramycin (as sulfate) 500mg/5 mL Injection vial - TGA Drug Approval Details
